These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10401882)

  • 1. Hormone replacement therapy and colon cancer among members of a health maintenance organization.
    Jacobs EJ; White E; Weiss NS; Heckbert SR; LaCroix A; Barlow WE
    Epidemiology; 1999 Jul; 10(4):445-51. PubMed ID: 10401882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
    Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Weiss NS; Larson EB; Rosendaal FR; Psaty BM
    JAMA; 2004 Oct; 292(13):1581-7. PubMed ID: 15467060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal hormone use and risk of large-bowel cancer.
    Newcomb PA; Storer BE
    J Natl Cancer Inst; 1995 Jul; 87(14):1067-71. PubMed ID: 7616598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of food groups and water intake to colon cancer risk.
    Shannon J; White E; Shattuck AL; Potter JD
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):495-502. PubMed ID: 8827352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogens, progesterone, and endometrial cancer.
    Jick SS; Walker AM; Jick H
    Epidemiology; 1993 Jan; 4(1):20-4. PubMed ID: 8380547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a formulary switch from conjugated to esterified estrogens in a managed care setting.
    Andrade SE; Gurwitz JH; Cernieux J; Fish LS
    Med Care; 2000 Sep; 38(9):970-5. PubMed ID: 10982118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy in relation to survival in women diagnosed with colon cancer.
    Mandelson MT; Miglioretti D; Newcomb PA; Harrison R; Potter JD
    Cancer Causes Control; 2003 Dec; 14(10):979-84. PubMed ID: 14750537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA).
    Jacobs EJ; White E; Weiss NS
    Cancer Causes Control; 1994 Jul; 5(4):359-66. PubMed ID: 8080948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Ross RK; Paganini-Hill A; Wan PC; Pike MC
    J Natl Cancer Inst; 2000 Feb; 92(4):328-32. PubMed ID: 10675382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer.
    Slattery ML; Potter JD; Curtin K; Edwards S; Ma KN; Anderson K; Schaffer D; Samowitz WS
    Cancer Res; 2001 Jan; 61(1):126-30. PubMed ID: 11196149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constipation, laxative use, and colon cancer among middle-aged adults.
    Jacobs EJ; White E
    Epidemiology; 1998 Jul; 9(4):385-91. PubMed ID: 9647901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decline in incidence of endometrial cancer following increase in prescriptions for opposed conjugated estrogens in a prepaid health plan.
    Ziel HK; Finkle WD; Greenland S
    Gynecol Oncol; 1998 Mar; 68(3):253-5. PubMed ID: 9570976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
    Ettinger B; Pressman A; Bradley C
    Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen plus progestin and risk of venous thrombosis.
    Cushman M; Kuller LH; Prentice R; Rodabough RJ; Psaty BM; Stafford RS; Sidney S; Rosendaal FR;
    JAMA; 2004 Oct; 292(13):1573-80. PubMed ID: 15467059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of endometrial cancer in relation to use of low-dose, unopposed estrogens.
    Cushing KL; Weiss NS; Voigt LF; McKnight B; Beresford SA
    Obstet Gynecol; 1998 Jan; 91(1):35-9. PubMed ID: 9464717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.
    Waters DD; Alderman EL; Hsia J; Howard BV; Cobb FR; Rogers WJ; Ouyang P; Thompson P; Tardif JC; Higginson L; Bittner V; Steffes M; Gordon DJ; Proschan M; Younes N; Verter JI
    JAMA; 2002 Nov; 288(19):2432-40. PubMed ID: 12435256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
    Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
    JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability of a substitution of estrogen replacement therapy to women enrolled in a health maintenance organization.
    Gardner J; Scholes D; Baluch W; Krauss R
    J Womens Health; 1998 Oct; 7(8):1027-31. PubMed ID: 9812299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States).
    Slattery ML; Ballard-Barbash R; Edwards S; Caan BJ; Potter JD
    Cancer Causes Control; 2003 Feb; 14(1):75-84. PubMed ID: 12708728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy and the risk of breast cancer. Nested case-control study in a cohort of Swedish women attending mammography screening.
    Persson I; Thurfjell E; Bergstrom R; Holmberg L
    Int J Cancer; 1997 Sep; 72(5):758-61. PubMed ID: 9311590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.